Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
16 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
HLG from Genk, company number BE0697858283, closed financial year 2025 with a result of € 0 after tax. For that financial year HLG recorded a gross margin of € 8,775 and equity of € 18,600. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
€ 18,600
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 195,990
▲ 53% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 9,319
▲ 31% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 11,794,449 | € 13,534,135 | - | - | |
| Gross margin | - | - | € 4,477 | € 8,775 | ▲ 96% |
| Equity | € 22,700 | € 18,600 | € 18,600 | € 18,600 | |
| Total debts | € 5,755,871 | € 6,116,530 | € 5,179,351 | € 5,639,582 | ▲ 9% |
| Cash | € 160,686 | € 148,967 | € 128,008 | € 195,990 | ▲ 53% |
| Balance sheet total | € 5,778,571 | € 6,135,130 | € 5,197,951 | € 5,658,182 | ▲ 9% |
Key figures of HLG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to HLG?
What happened at HLG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
- VISCOR BV became a director. NBB
- DR. PH.BERTRAND BV became a director. NBB
- DR. MATTHIAS DUPONT BV became a director. NBB
- DOKTER YVES CRUYSBERGHS BV became a director. NBB
- New establishment in Hoeselt. KBO
- New establishment in Genk. KBO
- Start of the company according to the CBE. KBO
In short
From € 0 profit in 2022 to € 0 profit in 2025.
A new publication or filing at HLG? We notify you, reason included.
Follow HLGDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of CARDIOLOGIE PIETER MARTENS, Dr. Matthias Dupont, DR. RIVERO, VISCOR, Muwi, Dr. Geert JEURISSEN, DR. M. HULSELMANS, DOKTER YVES CRUYSBERGHS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
HLGBehind HLG are VISCOR BV, DR. PH.BERTRAND BV, DR. MATTHIAS DUPONT BV and DOKTER YVES CRUYSBERGHS BV. The shares are held by CARDIOLOGIE PIETER MARTENS (50%), Dr. Matthias Dupont (8.3%), DR. RIVERO (8%), VISCOR (5%), Muwi (3.3%) and Dr. Geert JEURISSEN (0.1%).
Directors
According to the 2025 annual accounts
Director · represented by FERDINANDE BERT
since 2025
since 2025
since 2025
Director · represented by YVES CRUYGSBERGHTS
Also active at: CARDIOTRIALS ZOL
since 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Synaps Park 1
3600 Genk
Tongersesteenweg 18-22
3730 Hoeselt
Active since 5 September 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
All companies at this address →Ziekenhuis Oost-Limburg, autonome verzorgingsinstelling
Werkgroep Endovasculaire Heelkunde en Vaatdiagnostiek
DR. JAARKE VANNOOTE-GASTRO-ENTEROLOOG
€ 414,126 gross margin · 2025
Feitelijke organisatie plastische heelkunde ZOL Genk
Associatie Neurologie Ziekenhuis Oost - Limburg fv
+11 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0697.858.283
- VAT number
- BE 0697.858.283
- Registered office
- Synaps Park 1, 3600 Genk
- Names & denominations
- HLG
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 May 2018
- Peppol
- Active · Active since 17 Mar 2025
- Activities · NACE
Activiteiten van medisch specialisten